SENS-AI
AFH Results Bullish

ALEXANDER FORBES GROUP HOLDINGS LIMITED - Extract of the audited results for the year ended 31 March 2026 and cash dividend announcement

Alexander Forbes Group Holdings Limited
Full analysis

What this filing means

Alexander Forbes delivered strong audited full-year results with operating income up 10% and a 4% dividend increase, supported by robust cash generation and asset growth despite a 5% drop in headline earnings.

Alexander Forbes reported a solid year, growing its core business profits and cash flow enough to increase the dividend paid to shareholders. The slight drop in headline earnings was mostly due to businesses they sold last year, rather than a problem with their current operations.

Bull case

  • Operating income from continuing operations grew by 10% to R4 848 million, supported by positive investment performance and strong new business flows.
  • Normalised profit from operations expanded by 22% to R1 027 million, demonstrating solid underlying operating margin improvement.
  • Cash generated from operations rose 20% to R1 472 million, strengthening a balance sheet that boasts a robust 2.2 times capital cover ratio.
  • The board declared a 4% increase in the annual dividend to 57 cents per share, as the CEO highlighted that consistent execution is yielding practical steps in simplifying the business.

Bear case

  • Total Group headline earnings per share (HEPS) declined by 5% to 67.0 cents, as the base effect of prior-year discontinued operations weighed on the bottom line.
  • Operating expenses increased by 9% year-on-year to R3 854 million, with 4% of this growth attributed to accounting changes and IFRS 16 lease adjustments.
  • The Health consulting division faced competitive pricing pressure and lost business, while the impact advisory business underperformed management's expectations.
View original SENS announcement

AI-generated summary by SENS-AI, based on the original JSE SENS filing.

SENS-AI conclusion

Alexander Forbes has released its audited results for the year ended 31 March 2026, reporting a 10% rise in operating income, a 22% increase in normalised profit from operations, and a 4% increase in the annual dividend. The robust 20% growth in operating cash flow and a 22% expansion in total assets to R733 billion confirm strong underlying operational momentum, more than offsetting the 5% optical decline in total HEPS caused by prior-year discontinued operations. This filing does not guarantee that the ongoing multi-year IT system upgrades will deliver the targeted cost efficiencies by 2028 without implementation friction. Investor Takeaway: Solid cash conversion, asset growth, and an increased dividend validate the group's operational stability, even as legacy accounting and platform transitions muddy the headline earnings figure. Signal-to-Price Note: The stock is down 1.28% today despite the fundamentally strong update, which may reflect the market focusing on the optical HEPS decline or broader sector positioning.

Strong cash conversion and asset growth confirm the operational thesis. The dividend yield provides a solid anchor, and the underlying growth profile remains intact.

Decision framework

Current stance: Filing Positive

Key drivers

  • Operating income from continuing operations grew by 10% to R4 848 million, supported by positive investment performance and strong new business flows.
  • Normalised profit from operations expanded by 22% to R1 027 million, demonstrating solid underlying operating margin improvement.
  • Cash generated from operations rose 20% to R1 472 million, strengthening a balance sheet that boasts a robust 2.2 times capital cover ratio.

Key risks

  • Total Group headline earnings per share (HEPS) declined by 5% to 67.0 cents, as the base effect of prior-year discontinued operations weighed on the bottom line.
  • Operating expenses increased by 9% year-on-year to R3 854 million, with 4% of this growth attributed to accounting changes and IFRS 16 lease adjustments.
  • The Health consulting division faced competitive pricing pressure and lost business, while the impact advisory business underperformed management's expectations.

What would change the view

  • Forward guidance is cut or withdrawn in the next update.
  • Cash-flow conversion deteriorates relative to reported earnings.
  • Positive thesis fails to hold through the next reporting window.

Evidence from the filing

  • Operating income from continuing operations grew by 10% to R4 848 million, supported by positive investment performance and strong new business flows.

    “Operating income(A) 10 4 848 4 397 3 905”

  • Normalised profit from operations expanded by 22% to R1 027 million, demonstrating solid underlying operating margin improvement.

    “Normalised profit from operations (before non-trading and capital items) 22 1 027 841 661”

  • Cash generated from operations rose 20% to R1 472 million, strengthening a balance sheet that boasts a robust 2.2 times capital cover ratio.

    “Cash generated from operations 20 1 472 1 230 1 073”

  • The board declared a 4% increase in the annual dividend to 57 cents per share, as the CEO highlighted that consistent execution is yielding practical steps in simplifying the business.

    “Annual dividend per share (cents) 4 57.0 55.0 50.0”

  • Total Group headline earnings per share (HEPS) declined by 5% to 67.0 cents, as the base effect of prior-year discontinued operations weighed on the bottom line.

    “Headline earnings per share from total operations decreased 5% to 67 cents per share.”

  • Operating expenses increased by 9% year-on-year to R3 854 million, with 4% of this growth attributed to accounting changes and IFRS 16 lease adjustments.

    “Operating expenses of R3 854 million increased 9% year on year of which 4% relates to the change in accounting for our long-term incentive scheme and the prior year effect of the IFRS 16 lease adjustment.”

  • The Health consulting division faced competitive pricing pressure and lost business, while the impact advisory business underperformed management's expectations.

    “Health consulting faced competitive and pricing pressure, including the impact of lost business and the impact advisory business underperformed relative to expectations.”
Category
Results
Event posture
Constructive
Published
Jun 11, 2026

More on Alexander Forbes Group Holdings Limited

Alexander Forbes Group Holdings Limited (AFH) share price All Alexander Forbes Group Holdings Limited SENS announcements

Related filings